| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/08/1999 | WO1999033992A1 Murine intracisternal a particle constitutive transport elements and uses thereof |
| 07/08/1999 | WO1999033991A2 TOXINS ACTIVE AGAINST $i(OSTRINIA NUBILALIS) |
| 07/08/1999 | WO1999033990A1 HUMAN CXC CHEMOKINE (Tim-1) |
| 07/08/1999 | WO1999033989A2 Rantes mutants and therapeutic applications thereof |
| 07/08/1999 | WO1999033988A1 A process for preparing human proinsulin |
| 07/08/1999 | WO1999033987A1 Cloning of a high growth gene |
| 07/08/1999 | WO1999033986A1 MAMMALIAN ENHANCER OF POLYCOMB (epc) ACTS AS A TUMOR SUPPRESSOR |
| 07/08/1999 | WO1999033985A2 C1F150/hTAFII150 IS NECESSARY FOR CELL CYCLE PROGRESSION |
| 07/08/1999 | WO1999033984A1 V197 dna and polypeptides |
| 07/08/1999 | WO1999033983A1 V201 dna and polypeptides |
| 07/08/1999 | WO1999033982A2 Human genes and gene expression products i |
| 07/08/1999 | WO1999033981A2 Human signal peptide-containing proteins |
| 07/08/1999 | WO1999033980A2 Members of tnf and tnfr families |
| 07/08/1999 | WO1999033979A2 Bone marrow secreted proteins and polynucleotides |
| 07/08/1999 | WO1999033978A1 Novel guanosine triphosphate (gtp)-binding protein conjugate type receptor proteins |
| 07/08/1999 | WO1999033977A1 Tumor antigen protein, gene thereof, and utilization thereof |
| 07/08/1999 | WO1999033976A1 Polypeptide, their production and use |
| 07/08/1999 | WO1999033975A1 Heat shock transcription factor-binding protein |
| 07/08/1999 | WO1999033974A1 Serine proteinase inhibitors |
| 07/08/1999 | WO1999033973A2 Cloned octapamine-receptor-producing cells |
| 07/08/1999 | WO1999033972A1 Mammalian edg-5 receptor homologs |
| 07/08/1999 | WO1999033971A1 Oligomers that bind to ku protein |
| 07/08/1999 | WO1999033970A1 Medicinal compositions for treating or preventing influenza and novel capped oligoribonucleotides |
| 07/08/1999 | WO1999033969A1 A method of isolating a peptide which immunologically mimics microbial carbohydrates including group b streptococcal carbohydrates and the use thereof in a vaccine |
| 07/08/1999 | WO1999033967A2 Novel nucleic acid and polypeptide with homology to the tnf-receptors |
| 07/08/1999 | WO1999033965A1 Bifunctional molecules |
| 07/08/1999 | WO1999033963A1 Metastatic cancer regulated gene |
| 07/08/1999 | WO1999033962A1 HUMAN CYCLIN-DEPENDENT KINASE (hPFTAIRE) |
| 07/08/1999 | WO1999033961A1 Novel kinase |
| 07/08/1999 | WO1999033959A2 Proteases from gram positive organisms |
| 07/08/1999 | WO1999033958A2 Desaturase |
| 07/08/1999 | WO1999033956A1 Sex-specific insemination of mammals with low number of sperm cells |
| 07/08/1999 | WO1999033878A1 Monoclonal antibody against connective tissue growth factor and medicinal uses thereof |
| 07/08/1999 | WO1999033877A1 V196 dna and polypeptides |
| 07/08/1999 | WO1999033876A1 Novel seven-pass transmembrane receptor protein |
| 07/08/1999 | WO1999033874A1 Troponin ci complexes |
| 07/08/1999 | WO1999033873A1 NOVEL POLYPEPTIDES, cDNAS ENCODING THE SAME AND UTILIZATION THEREOF |
| 07/08/1999 | WO1999033871A2 Essential bacterial genes and their use |
| 07/08/1999 | WO1999033870A2 Human regulatory proteins |
| 07/08/1999 | WO1999033869A2 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |
| 07/08/1999 | WO1999033868A2 Human papillomavirus vaccine |
| 07/08/1999 | WO1999033862A1 Free solution ligand interaction molecular separation method |
| 07/08/1999 | WO1999033488A2 Adjuvanted vaccine formulation |
| 07/08/1999 | WO1999033485A1 Expression vectors and cell lines expressing vascular endothelial growth factor d, and method of treating melanomas |
| 07/08/1999 | WO1999033482A1 Uses of alpha-conotoxin peptides |
| 07/08/1999 | WO1999023228B1 Svph1-26 dna and polypeptides |
| 07/08/1999 | WO1999021994A3 Human vesicle membrane protein-like proteins |
| 07/08/1999 | WO1999021976A3 Rapid generation of stable mammalian cell lines producing high levels of recombinant proteins |
| 07/08/1999 | WO1999021574A3 Enhancement of morphogen activity |
| 07/08/1999 | WO1999020760A3 Herg family potassium ion channel genes and protein |
| 07/08/1999 | WO1999019482A3 Vesicle transport associated proteins |
| 07/08/1999 | WO1999019466A3 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities |
| 07/08/1999 | WO1999018226A3 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
| 07/08/1999 | WO1999015662A9 Telomere repeat binding factors and diagnostic and therapeutic use thereof |
| 07/08/1999 | WO1999014231A3 Bifidus stimulating peptides and its uses |
| 07/08/1999 | WO1999011794A3 New vrk1 kinase |
| 07/08/1999 | WO1999010510A3 Fusion proteins comprising a dimerization, trimerization or tetramerization domain and an additional heterologous transcription activation, transcription repression, dna binding or ligand binding domain |
| 07/08/1999 | WO1999005288A3 Method for producing and identifying new hydrolases having improved properties |
| 07/08/1999 | WO1999004810A3 Use of mhc class ii ligands as adjuvant for vaccination and of lag-3 in cancer treatment |
| 07/08/1999 | WO1999004265A9 Cancer associated nucleic acids and polypeptides |
| 07/08/1999 | WO1999002676A3 Mutants of gef proteins |
| 07/08/1999 | WO1998048046A3 Taqmantm-pcr for the detection of pathogenic e. coli strains |
| 07/08/1999 | WO1998045711A3 Assay for ligands to tyrosine kinase receptors |
| 07/08/1999 | WO1998035060A8 Polymerases for analyzing or typing polymorphic nucleic acid fragments and uses thereof |
| 07/08/1999 | CA2823259A1 Sex-specific insemination of mammals with low number of sperm cells |
| 07/08/1999 | CA2317111A1 Delivery of polypeptide-encoding plasmid dna into the cytosol of macrophages by attenuated suicide bacteria |
| 07/08/1999 | CA2317029A1 A method of isolating a peptide which immunologically mimics microbial carbohydrates including group b streptococcal carbohydrates and the use thereof in a vaccine |
| 07/08/1999 | CA2316990A1 Plant galactose dehydrogenase |
| 07/08/1999 | CA2316545A1 Novel nucleic acid and polypeptide with homology to the tnf-receptors |
| 07/08/1999 | CA2316403A1 Mammalian edg-5 receptor homologs |
| 07/08/1999 | CA2316401A1 Modified deacetoxycephalosporin c synthase (daocs) and x-ray structure |
| 07/08/1999 | CA2316397A1 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |
| 07/08/1999 | CA2316396A1 Tumor antigen protein, gene thereof, and utilization thereof |
| 07/08/1999 | CA2316283A1 Novel guanosine triphosphate (gtp) binding protein-coupled receptor protein |
| 07/08/1999 | CA2316282A1 Regulatory dna sequences of the human catalytic telomerase sub-unit gene, diagnostic and therapeutic use thereof |
| 07/08/1999 | CA2316080A1 Sex-specific insemination of mammals with low number of sperm cells |
| 07/08/1999 | CA2316079A1 Human regulatory proteins |
| 07/08/1999 | CA2316017A1 Reagents and methods useful for detecting diseases of the breast |
| 07/08/1999 | CA2316016A1 V197 dna and polypeptides |
| 07/08/1999 | CA2315977A1 Expression vectors and cell lines expressing vascular endothelial growth factor d, and method of treating melanomas |
| 07/08/1999 | CA2315944A1 Bifunctional molecules |
| 07/08/1999 | CA2315879A1 V201 dna and polypeptides |
| 07/08/1999 | CA2315750A1 A process for preparing human proinsulin |
| 07/08/1999 | CA2315702A1 V196 dna and polypeptides |
| 07/08/1999 | CA2315617A1 Human signal peptide-containing proteins |
| 07/08/1999 | CA2315534A1 Promoter from ashbya gossypii |
| 07/08/1999 | CA2315297A1 Desaturase |
| 07/08/1999 | CA2315296A1 Solid-phase tips and uses relating thereto |
| 07/08/1999 | CA2315276A1 Human papillomavirus vaccine |
| 07/08/1999 | CA2315252A1 Essential bacterial genes and their use |
| 07/08/1999 | CA2315106A1 Toxins active against ostrinia nubilalis |
| 07/08/1999 | CA2313246A1 Polypeptide, their production and use |
| 07/08/1999 | CA2312733A1 Troponin ci complexes |
| 07/07/1999 | EP0927765A1 Method for selecting transformed cells |
| 07/07/1999 | EP0927764A2 Chimeric serine proteases |
| 07/07/1999 | EP0927763A2 Novel aroA |
| 07/07/1999 | EP0927761A2 Purinebiosynthesis genes from Ashbya possypii and use for the microbial Riboflavinsynthesis |
| 07/07/1999 | EP0927760A2 Immunreactive parts of the glycoproteins gpII from Varicell-Zoster-Virus |
| 07/07/1999 | EP0927759A2 Immunoreactive protein VP26 of Varicella Zoster Virus (VZV) and its diagnostic use |
| 07/07/1999 | EP0927758A2 Recombinant antibodies specific for TNF-Alpha |